Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
Seminar

[TOP] [Previous Slide] [Next Slide]

Dick Swaab and Ahmad Salehi

Slide 7

OUR APOLOGIES: IMAGES UNAVAILABLE

In my opinion, metabolic decrease is one of the main hallmarks of Alzheimer's disease. What then may cause this metabolic decrease? We think that the high-affinity receptors for neurotrophins might be a key factor in this.

In a control subject, the high-affinity Trk-A receptor is present in the cell bodies of the nucleus basalis of Mynert. In Alzheimer's patients you can see the cell but no Trk-A receptors are present anymore in the cell bodies. This means that the main transport mechanism for neurotrophins which are collected from the cortical areas by those cells is lacking in Alzheimer's disease. In Alzheimer's patients, the percentage of cells which contain Trk A, B or C, three types of high-affinity neurotrophin receptors, is very strongly decreased in all three types. It is the number of cells containing this high-affinity receptor, Trk-A, that is affected most clearly.

This gives an alternative hypothesis to the pathogenesis of Alzheimer's disease, which we see as a multifactorial disease. Many factors might cause it probably on the basis of the aging process, an acceleration of the process such that dementia results. But the signs that we know so well from neuropathology have to be considered as independent of the dementia. Atrophy--inactivity of neurons--is in my opinion much more important. Of course there are also protective factors which seem to be different in different brain areas but in general they have to do something with activation. Whereas those factors which cause an acceleration of the process, like ApoE 4, cause decreased activity in neurons.

Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad